Anti-epileptic Action of Thymoquinone

  • Habibullah Khalilullah


A number of studies have been carried out to establish the anti-epileptic activity of N. sativa. Thymoquinone (TQ) is found in volatile oil of the plant and is considered the main constituent responsible for its anti-epileptic effect. Mechanism of action of TQ on seizures is not completely established; however some researchers believe that it produces anticonvulsant effect by interacting with gamma-aminobutyric acid (GABA). Some researchers in their study found that the co-administration of TQ and some known anti-epileptic drugs led to the potentiation of their anti-epileptic effect and suppressed their adverse effects.


  1. Abdel-Zaher AO, Farghaly SM, Farrag MMY et al (2017) A potential mechanism for the ameliorative effect of thymoquinone on pentylenetetrazole-induced kindling and cognitive impairments in mice. Biomed Pharmacother 88:553–561CrossRefGoogle Scholar
  2. Acharya MM, Hattiangady B, Shetty AK (2008) Progress in neuroprotective strategies for preventing epilepsy. Prog Neurobiol 84:363–404CrossRefGoogle Scholar
  3. Akhondian J, Kianifar H, Raoofziaee M et al (2011) The effect of thymoquinone on intractable pediatric seizures (pilot study). Epilepsy Res 93:39–43CrossRefGoogle Scholar
  4. Ali BH, Blunden G (2003) Pharmacological and toxicological properties of Nigella sativa. Phytother Res 17:299–305CrossRefGoogle Scholar
  5. Beyazcicek E, Ankarali S, Beyazcicek O et al (2016) Effects of thymoquinone, the major constituent of Nigella sativa seeds, on penicillin-induced epileptiform activity in rats. Neuroscience 21(2):131–137CrossRefGoogle Scholar
  6. Dakhakhny ME (1963) Studies on the chemical constitution of Egyptian N. sativa L. seeds. Planta Med 11:465–470CrossRefGoogle Scholar
  7. Dariani S, Baluchnejadmojarad T, Roghani M (2013) Thymoquinone attenuates astrogliosis, neurodegeneration, mossy fiber sprouting, and oxidative stress in a model of temporal lobe epilepsy. J Mol Neurosci 51(3):679–678CrossRefGoogle Scholar
  8. Dichter MA (2006) Models of epileptogenesis in adult animals available for antiepileptogenesis drug screening. Epilepsy Res 68:31–35CrossRefGoogle Scholar
  9. Engel J (1995) Concepts of epilepsy. Epilepsia 36:23–30CrossRefGoogle Scholar
  10. Fisher RS, Acevedo C, Arzimanoglou A et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475–482CrossRefGoogle Scholar
  11. Freitas RM, Vasconcelos SM, Souza FC et al (2005) Oxidative stress in the hippocampus after pilocarpine-induced status epilepticus in Wistar rats. FEBS J 272:1307–1312CrossRefGoogle Scholar
  12. Hamdy NM, Taha RA (2009) Effects of Nigella sativa oil and thymoquinone on oxidative stress and neuropathy in streptozotocin-induced diabetic rats. Pharmacology 84(3):127–134CrossRefGoogle Scholar
  13. Hosseinzadeh H, Parvardeh S (2004) Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds in mice. Phytomedicine 11:56–64CrossRefGoogle Scholar
  14. Hosseinzadeh H, Parvardeh S, Asl MN (2007) Effect of thymoquinone and Nigella sativa seeds oil on lipid peroxidation level during global cerebral ischemia-reperfusion injury in rat hippocampus. Phytomedicine 14(9):621–627CrossRefGoogle Scholar
  15. Hosseinzadeh H, Parvardeh S, Nassiri-Asl M et al (2005) Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats. Med Sci Monit 11(4):BR106–BR110Google Scholar
  16. Ikram Ullah, Badshah HM, Naseer MI et al (2015) Thymoquinone and vitamin C attenuates pentylenetetrazole-induced seizures via activation of gabab1 receptor in adult rats cortex and hippocampus. NeuroMolecular Med 17:35–46CrossRefGoogle Scholar
  17. Jokeit H, Schacher M (2004) Neuropsychological aspects of type of epilepsy and etiological factors in adults. Epilepsy Behav 5:S14–S20CrossRefGoogle Scholar
  18. Loscher W (2002) Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs: a comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50:105–123CrossRefGoogle Scholar
  19. Loscher W, Schmidt D (2006) New horizons in the development of antiepileptic drugs: innovative strategies. Epilepsy Res 69:183–272CrossRefGoogle Scholar
  20. Mostafa RM, Moustafa YM, Mirghanil Z (2012) Thymoquinone alone or in combination with phenobarbital reduces the seizure score and the oxidative burden in pentylenetetrazole-kindled rats. Oxid Antioxid Med Sci 1:185–192CrossRefGoogle Scholar
  21. Raza M, Alghasham AA, Alorainy MS et al (2006) Beneficial interaction of thymoquinone and sodium valproate in experimental models of epilepsy: reduction in hepatotoxicity of valproate. Sci Pharm 74:159–173CrossRefGoogle Scholar
  22. Salmani JM, Asghar S, Zhou H, Lv J (2014) Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light. Molecules 19:5925–5939CrossRefGoogle Scholar
  23. Stefan H, Lopes da Silva FH, Loscher W et al (2006) Epileptogenesis and rational therapeutic strategies. Acta Neurol Scand 113(3):139–155CrossRefGoogle Scholar
  24. Waldbaum S, Patel M (2010) Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res 88:23–45CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Habibullah Khalilullah
    • 1
  1. 1.Department of Pharmaceutical Chemistry and PharmacognosyUnaizah College of Pharmacy, Qassim UniversityUnaizahKingdom of Saudi Arabia

Personalised recommendations